For 2018, Discovery on Target presents four full conference tracks dedicated to developments of novel and differentiated therapeutic antibodies for challenging targets and indications. The two-part Antibodies Against Membrane Protein Targets, now in its
sixth year, explores the pursuit of antibodies against the very challenging ion channel and GPCR target classes. The meeting details best practices and emerging discovery technologies in this space and provides important updates on programs now advancing
through preclinical and clinical development. And new for 2018, the two-part Antibody Discovery Forum offers a unique discussion-focused conference format that provides researchers the opportunity to interact with colleagues facing similar challenges.
Part 1, Discovery Technologies and Methods, steps through the discovery workflow, exploring how the many new technologies now in use are being integrated into R&D groups across the industry. Part 2, Discovery of Novel Cancer Immunotherapies, then
considers how new technologies and scientific understandings are being applied in the early stage quest to identify prospects for novel cancer immunotherapies.